Lisata Therapeutics, Inc. (LSTA)
1.935
+0.08
(+4.03%)
USD |
NASDAQ |
Sep 09, 12:39
Lisata Therapeutics Price : 1.935 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.65 | 1.89 | 1.62 | 1.86 | 252498.0 |
| Sep 04, 2026 | 1.58 | 1.70 | 1.564 | 1.65 | 33923.00 |
| Sep 03, 2026 | 1.57 | 1.71 | 1.45 | 1.64 | 162868.0 |
| Sep 02, 2026 | 1.52 | 1.64 | 1.45 | 1.57 | 113612.0 |
| Sep 01, 2026 | 1.48 | 1.64 | 1.234 | 1.57 | 475598.0 |
| Aug 31, 2026 | 1.66 | 1.66 | 1.44 | 1.49 | 243389.0 |
| Aug 28, 2026 | 1.80 | 1.815 | 1.54 | 1.69 | 245048.0 |
| Aug 27, 2026 | 1.76 | 1.940 | 1.76 | 1.82 | 86666.00 |
| Aug 26, 2026 | 1.76 | 1.87 | 1.75 | 1.81 | 51732.00 |
| Aug 25, 2026 | 1.75 | 1.90 | 1.72 | 1.74 | 184300.0 |
| Aug 24, 2026 | 1.63 | 2.00 | 1.60 | 1.76 | 1.094M |
| Aug 21, 2026 | 1.11 | 1.79 | 1.104 | 1.55 | 7.121M |
| Aug 20, 2026 | 1.13 | 1.165 | 1.07 | 1.12 | 94818.00 |
| Aug 19, 2026 | 1.11 | 1.225 | 1.08 | 1.12 | 167482.0 |
| Aug 18, 2026 | 1.10 | 1.20 | 1.10 | 1.15 | 35070.00 |
| Aug 17, 2026 | 1.09 | 1.157 | 1.08 | 1.08 | 21543.00 |
| Aug 14, 2026 | 1.10 | 1.15 | 1.05 | 1.09 | 24984.00 |
| Aug 13, 2026 | 1.19 | 1.19 | 1.10 | 1.13 | 31490.00 |
| Aug 12, 2026 | 1.21 | 1.279 | 1.12 | 1.18 | 37582.00 |
| Aug 11, 2026 | 1.07 | 1.25 | 1.07 | 1.21 | 120244.0 |
| Aug 10, 2026 | 1.05 | 1.11 | 1.02 | 1.09 | 104198.0 |
| Aug 07, 2026 | 1.067 | 1.09 | 1.04 | 1.06 | 23489.00 |
| Aug 06, 2026 | 1.12 | 1.12 | 1.06 | 1.07 | 27077.00 |
| Aug 05, 2026 | 1.14 | 1.14 | 1.064 | 1.12 | 55308.00 |
| Aug 04, 2026 | 1.02 | 1.22 | 0.9901 | 1.14 | 162633.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.73 |
| Alnylam Pharmaceuticals, Inc. | 255.71 |
| Anika Therapeutics, Inc. | 20.96 |
| Savara, Inc. | 5.38 |
| Vericel Corp. | 38.82 |
Price Related Metrics
| PS Ratio | 172.62 |
| Price to Book Value | 2.140 |
| Earnings Yield | -84.80% |
| Market Cap | 17.65M |